Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Medtronic
Cerilliant
Healthtrust
UBS
Accenture
Daiichi Sankyo
Chinese Patent Office
QuintilesIMS
Baxter

Generated: October 21, 2017

DrugPatentWatch Database Preview

DEXTROAMPHETAMINE SULFATE Drug Profile

« Back to Dashboard

What is the patent landscape for Dextroamphetamine Sulfate, and when can generic versions of Dextroamphetamine Sulfate launch?

Dextroamphetamine Sulfate is a drug marketed by Actavis Elizabeth, Lannett, Nesher Pharms, Able, Mast Mm, Purepac Pharm, Halsey, Novel Labs Inc, Mikart, Mylan Pharms Inc, Mallinckrodt, Mayne Pharma, Tris Pharma Inc, Avanthi Inc, Epic Pharma Llc, Barr, Idt Australia Ltd, Sandoz, Outlook Pharms, Vitarine, Aurolife Pharma Llc, and Vintage Pharms Llc. and is included in twenty-eight NDAs.

The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There are seventeen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.

Summary for Tradename: DEXTROAMPHETAMINE SULFATE

US Patents:0
Applicants:22
NDAs:28
Suppliers / Packagers: see list23
Clinical Trials: see list671
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEXTROAMPHETAMINE SULFATE at DailyMed

Pharmacology for Tradename: DEXTROAMPHETAMINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL040361-001Jan 31, 2001AARXNoNo► Subscribe► Subscribe► Subscribe
Tris Pharma Inc
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
SOLUTION;ORAL203644-001May 29, 2013AARXNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL206588-001Mar 28, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Idt Australia Ltd
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL085370-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL206588-002Mar 28, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL040436-002Jan 29, 2002AARXNoNo► Subscribe► Subscribe► Subscribe
Avanthi Inc
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL203548-001Nov 23, 2015AARXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL076137-001Jan 18, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL203901-001Nov 30, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Mikart
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL090533-002Oct 25, 2011AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Mallinckrodt
Dow
Novartis
Johnson and Johnson
Merck
Healthtrust
McKinsey
Covington
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot